FDA approved device for migraine treatment

Cefaly is a non-drug, non-invasive migraine treatment that offers the best safety/efficacy ratio compared to current anti-migraine medication. It is the first line treatment for patients having frequent migraine attacks. Cefaly enables the use of medicines to be significantly reduced and the sufferer's quality of life to be markedly improved. Cefaly has been approved by the FDA for use under prescription.


What is Cefaly?

Cefaly is an External Trigeminal Nerve Stimulation device (e-TNS) for migraine treatment. A self-adhesive electrode is placed on the forehead and the Cefaly device is magnetically connected to this electrode. Precise micro-impulses are then sent through the electrode to the upper branch of the trigeminal nerve to either relieve the headache pain during a migraine attack (Acute setting) or to prevent future migraine attacks (Prevent setting).

Who is Cefaly for?

Cefaly is intended for patients who suffer from migraine -- with or without aura.

  • The Acute setting is indicated for the acute treatment of migraine attacks.
  • The Prevent setting is indicated for migraineurs who have three or more migraine attacks per month and need a preventive migraine treatment to reduce the frequency of episodes.
cefaly new generation, first line treatment against migraine